Home Ingredients Kinexa® (Joint Longevity Complex)
Joint Health

Kinexa® (Joint Longevity Complex)

Evidence Level
Preliminary
1 Clinical Trial
2 Documented Benefits
1/5 Evidence Score

Kinexa® (PLT Health Solutions) is a newly launched (2026) joint ingredient: a patented 200 mg blend of standardized Terminalia chebula (haritaki), Curcuma longa (turmeric), and Boswellia serrata (Indian frankincense) extracts. The maker reports a 6-month randomized placebo-controlled trial in 100 people with knee osteoarthritis, but that study has not been published in a peer-reviewed journal, so the evidence for Kinexa itself is preliminary. The two studies cited on this page test collagen, which Kinexa does not contain.

Studied Dose 200 mg once daily for 180 days in the manufacturer's randomized placebo-controlled knee-osteoarthritis trial (n=100). That trial is not yet published in a peer-reviewed journal.
Active Compound Patented 200 mg botanical blend (Kinexa®, PLT Health Solutions): standardized extracts of Terminalia chebula (haritaki, standardized to chebulagic and chebulinic acids), Curcuma longa (turmeric, standardized to curcuminoids), and Boswellia serrata (Indian frankincense, standardized to amyrins). Contains no collagen.

Benefits

Joint structure and mobility (manufacturer trial, not yet peer-reviewed)

In a 6-month randomized placebo-controlled trial run by the maker in 100 people with Grade II or III knee osteoarthritis, 200 mg/day of Kinexa® was reported to improve MRI cartilage thickness, WOMAC scores, knee strength, and walking speed. These results come from a conference abstract and have not been published in a peer-reviewed journal or independently replicated, so they should be read as preliminary. The two studies cited below are trials of collagen, which Kinexa® does not contain, and do not test this ingredient.

Supported by Trial 1

Strength and mobility for active aging

Kinexa is marketed to active-aging consumers who want to maintain joint function for continued activity. No published Kinexa trial has tested runners, athletes, or training performance, so this reflects marketing positioning rather than demonstrated evidence.

Supported by Trial 1

Mechanism of action

1

Musculoskeletal structure optimization

The three botanicals in Kinexa (turmeric, boswellia, Terminalia chebula) have anti-inflammatory and antioxidant activity in laboratory studies. How the finished blend affects cartilage, bone, or connective tissue in people has not been established in a published trial, and Kinexa contains no collagen.

Clinical trials

1
Kinexa®

Manufacturer-run trial of Kinexa® (PLT Health Solutions) in knee osteoarthritis, measuring joint structure by MRI plus strength and mobility. The full results are not published in a peer-reviewed journal; the only public output is a conference abstract from the company (Murphy, Salter, Kumar).

100 adults aged 40 to 75 with Grade II or III knee osteoarthritis (50 men, 50 women).

The maker reports a randomized, double-blind, placebo-controlled trial (n=100) giving 200 mg/day for 180 days, with MRI cartilage and WORMS scoring plus WOMAC, knee torque, and walk tests. Reported gains include roughly 10% greater cartilage thickness and improved WOMAC and strength scores. These results exist only as a conference abstract and have not been published in a peer-reviewed, PubMed-indexed journal, so they cannot be independently verified. The trial was run by the ingredient's maker.

Side effects and drug interactions

Common Potential side effects

Newly launched ingredient (2026). No independent safety data on the finished Kinexa blend has been published. The individual botanicals (turmeric, boswellia, Terminalia chebula) have a long history of oral use.
Safety information to date comes only from the manufacturer; no independent post-market safety evaluation of the blend has been published.

Important Drug interactions

No interaction studies of the Kinexa blend have been published. Turmeric and boswellia may add to the effect of blood-thinning medication, so consult a physician if you take anticoagulants.

More Joint Health Ingredients

Joint Health
Boswellia Serrata
Boswellia Serrata is a resin extract from the boswellia tree (Indian frankincense) used in…
Joint Health
Casperome® (Boswellia Phytosome — Indena)
Casperome® is Indena's phytosome-formulated Boswellia serrata extract — addressing the maj…
Joint Health
Boswellin® / Boswellin® Super (Standardized Boswellia serrata — Sabinsa)
Boswellin® is Sabinsa's branded Boswellia serrata gum resin extract, available in multiple…
Joint Health
SAMe (S-Adenosyl-L-Methionine)
S-Adenosyl-L-Methionine (SAMe) is a naturally occurring compound in the body, synthesized…

Frequently asked questions about Kinexa® (Joint Longevity Complex)

What is Kinexa?

Kinexa® (PLT Health Solutions) is a newly launched (2026) joint ingredient: a patented 200 mg blend of standardized Terminalia chebula (haritaki), Curcuma longa (turmeric), and Boswellia serrata (Indian frankincense) extracts.

What is Kinexa used for?

Kinexa is researched primarily for Joint Health. In a 6-month randomized placebo-controlled trial run by the maker in 100 people with Grade II or III knee osteoarthritis, 200 mg/day of Kinexa® was reported to improve MRI cartilage thickness, WOMAC scores, knee strength, and walking speed.

What is the recommended dosage of Kinexa?

The clinically studied dose is 200 mg once daily for 180 days in the manufacturer's randomized placebo-controlled knee-osteoarthritis trial (n=100). That trial is not yet published in a peer-reviewed journal. Always follow the product label and check with a healthcare provider for personal advice.

Is Kinexa safe, and does it have side effects?

For most healthy adults, Kinexa is well tolerated at studied doses. Reported effects can include: Newly launched ingredient (2026). No independent safety data on the finished Kinexa blend has been published. The individual botanicals (turmeric, boswellia, Terminalia chebula) have a long history of oral use. It may also interact with some medications. Kinexa is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Kinexa interact with any medications?

Possible interactions include: No interaction studies of the Kinexa blend have been published. Turmeric and boswellia may add to the effect of blood-thinning medication, so consult a physician if you take anticoagulants. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Kinexa?

NutraSmarts rates the evidence for Kinexa as Preliminary (1 out of 5). It is backed by 1 clinical trial and 2 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(2 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Chen CC, Chang SS, Chang CH, Hu CC, Nakao Y, Yong SM, Mandy YLO, Lim CJ, Shim EK, Shih HN Randomized, double-blind, four-arm pilot study on the effects of chicken essence and type II collagen hydrolysate on joint, bone, and muscle functions Nutrition Journal. 2023;22(1):17. doi:10.1186/s12937-023-00837-w.PubMedUsed to support: A four-arm industry-funded pilot in older adults found that chicken essence plus type II collagen hydrolysate lowered VAS pain and raised fat-free mass, but knee WOMAC scores improved about equally in every arm including placebo. This is a study of collagen and chicken essence, not of Kinexa, which contains neither.
  2. Bongers CCWG, Ten Haaf DSM, Catoire M, de Groot LCPGM, Eijsvogels TMH Effectiveness of collagen supplementation on pain scores in healthy individuals with self-reported knee pain Applied Physiology, Nutrition, and Metabolism. 2020;45(7):793-800. doi:10.1139/apnm-2019-0654.PubMedUsed to support: A 12-week randomized placebo-controlled trial found that collagen peptides did NOT reduce knee pain and did not change cartilage, bone, or inflammatory markers: knee pain and function improved about equally in the collagen and placebo groups. This is a null collagen trial, and Kinexa contains no collagen, so it does not support this ingredient.